Exelixis, Inc. EXEL
58.16
0.21
0.36%
as of 25 Sep
- Market cap
- $14.4B
- P/E
- 17.6×
Follow EXEL
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
30.56% | 35.53% | 40.99% | 44.39% | |
| 23.44% | 27.02% | 30.69% | 33.28% | ||
ROIC |
42.67% | 49.46% | 50.53% | 60.45% | |
Return on Tangible Assets |
59.82% | 68.85% | 89.31% | 87.68% | |
Average Days of Receivables |
49.41 | 45.14 | 50.54 | 48.28 | |
Free Cash Flow per Share |
2.77 | 3.11 | 3.50 | 4.62 | |
Free Cash Flow |
744.27 | 844.34 | 905.17 | 1,158.19 | |
Capital Expenditures |
(46.75) | (39.93) | (19.51) | (25.24) | |
Piotroski F-Score |
6.00 | 5.00 | 5.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
25.12% | 27.46% | 34.08% | 44.11% | |
Accounts Receivable Turnover |
7.90 | 8.40 | 7.78 | 7.93 | |
Accounts Payable Turnover |
1.82 | 2.47 | 2.52 | 2.64 | |
Inventory Turnover |
3.19 | 3.80 | 3.28 | 3.28 | |
Average Days of Payables |
119.87 | 129.19 | 104.36 | 166.43 | |
Days of Inventory on Hand |
129.59 | 94.57 | 114.95 | 122.41 | |
Tax Rate |
(0.22) | (0.17) | (0.17) | (0.17) | |
Research and Development Expense of Revenue |
37.62% | 35.56% | 34.21% | 33.84% | |
Selling, General and Administrative Expense of Revenue |
23.16% | 22.36% | 21.94% | 21.92% | |
Share Based Compensation of Revenue |
5.21% | 4.87% | 4.89% | 4.62% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.17 | 1.13 | 1.11 | 1.38 | |
Depreciation/Fixed assets |
0.28 | 0.29 | 0.30 | 0.31 | |
Capex/Depreciation |
(1.57) | (1.37) | (0.68) | (0.89) | |
Revenue per Share |
8.52 | 8.54 | 9.20 | 9.71 | |
Operating CF per Share |
2.95 | 3.26 | 3.58 | 4.72 | |
Capex per Share |
(0.17) | (0.15) | (0.08) | (0.10) | |
Capex to Sales |
0.02 | 0.02 | 0.01 | 0.01 | |
Net Profit Margin |
29.63% | 33.73% | 35.08% | 35.33% |
Columns are period end dates